ERBB3: A Potential Serum Biomarker for Early Detection and Therapeutic Target for Devil Facial Tumour 1 (DFT1)

PLoS ONE - United States
doi 10.1371/journal.pone.0177919
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer

Journal of Oncology
Oncology
2018English

CD83 Is a New Potential Biomarker and Therapeutic Target for Hodgkin Lymphoma

Haematologica
Hematology
2018English

ROR2 Is a Novel Prognostic Biomarker and a Potential Therapeutic Target in Leiomyosarcoma and Gastrointestinal Stromal Tumour

Journal of Pathology
Forensic MedicinePathology
2012English

Transgelin in Bladder Cancer: A Potential Biomarker and Therapeutic Target

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

C-Met as a Potential Therapeutic Target and Biomarker in Cancer

Therapeutic Advances in Medical Oncology
Oncology
2011English

Systematic Approach Identifies RHOA as a Potential Biomarker Therapeutic Target for Asian Gastric Cancer

Oncotarget
Oncology
2016English

Saturated and Mono-Unsaturated Lysophosphatidylcholine Metabolism in Tumour Cells: A Potential Therapeutic Target for Preventing Metastases

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2015English

Kim-1/Tim-1: From Biomarker to Therapeutic Target?

Nephrology Dialysis Transplantation
MedicineTransplantationNephrology
2008English

Identification of Kininogen-1 as a Serum Biomarker for the Early Detection of Advanced Colorectal Adenoma and Colorectal Cancer

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy